The Global Organ Transplantation Market is expected to grow at a CAGR of 9.8% during forecasted period 2017-2023.
Organ Transplantation Market – Competitive Analysis
Novartis International AG (Switzerland), Sanofi (France), Pfizer, Inc. (US), Terumo Medical Corporation (US), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio Med Pvt. Ltd. (US), Astellas Pharma, Inc (Japan), OrganOX Limited (UK), Transplant Biomedical (UK), TransMedic, Inc. (US), Accord Healthcare GmbH (Spain), Veloxis Pharmaceuticals A/S (Denmark), Acelity L.P. Inc. (US), GlaxoSmithKline Plc. (UK), Preservation Solutions, Inc. (US), Arthrex, Inc. (US), Zimmer Biomet (US), Medtronic plc (US), Stryker (US), and others are some of the prominent players at the forefront of competition in the organ transplantation market and are profiled in MRFR Analysis.
The organ transplantation market is currently dominated by various players. Due to rising cases of organ failures, and related complications various existing and new marketers are continuously coming up with advanced devices. The global organ transplantation market is currently dominated by numerous players.
OrganOx is one of them by holding a strong share in the market. The company is a market leader in the field of organ preservation. OrganOx entered a five year agreement with Dismeval to distribute the OrganOx metra in Spain, in 2017.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/915 .
Organ Transplantation Market – Overview
The organ transplantation market is growing mainly due to growing awareness about organ transplantation, and increasing incidence of chronic diseases. According to a study report published by the Market Research Future, the organ transplantation market is booming and expected to gain prominence over the forecast period. The market is expected to demonstrate a spectacular growth by 2023, and will surpass its previous growth records in terms of value with a striking CAGR during the forecast period (2017 – 2023).
Due to high healthcare expenditure, and presence of major market players in this region such as Arthrex Inc., and Novartis AG, the Americas dominate the global organ transplantation market. According to the Centres for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.
Global organ transplantation market is classified on the basis of type of organ, products, type of transplant, and end user. On the basis of the type of type of organ, the market is classified as heart, kidney, liver, lungs, and other. On the basis of type of transplant the market is classified as autograft, xenograft and xenotransplantation, allograft and allotransplantation, and other. On the basis of type of products, the market is classified as transplant diagnostics, organ preservation solutions, tissue products and other. On the basis of end-user, the market is classified as hospitals, transplant centres, and others.
Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/915 .
Notably, increasing incidence of chronic diseases, rising research and development expenditure are the primary drivers for organ transplantation market. According to the report published in Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults dealing with at least one type of cardiovascular disease. Burden of chronic diseases is also observed in Asia Pacific countries. As per the study published in BMC Public Health in 2017, prevalence of type-2 diabetes, obesity, and cardiovascular disease has increased rapidly in recent years.
Other push factors such as, increasing number of tissue banks, rising geriatric population, advancement in surgical techniques, increasing urbanization and changing lifestyles, improvement in reimbursement policies, development in the field of tissue typing, developing medical device industries, are also fuelling the growth of the market.
Despite these drivers, shortage of organ donors for transplantation, side effects associated with available treatmet options, and strict FDA regulations, are expected to hinder the growth of the market during the forecast period.
Organ Transplantation Market – Regional Analysis
The Americas dominate the organ transplantation market owing to the presence of huge patient pool, increasing incidence of organ failure, well-developed technology, high healthcare expenditure, and the presence of leading market players. According to the National Institutes of Health, more than 661,000 Americans have kidney failure, and out of these, 468,000 individuals are on dialysis, and roughly 193,000 live with a functioning kidney transplant.
Europe holds the second position in the organ transplantation market. Chronic Kidney Disease (CKD) is also found to be highly prevalent in European population. According to the study published in the Journal of the American Society of Nephrology in 2015, prevalence rate of CKD stages 1–5 is 3.31% in Norway, and 17.3% in northeast Germany. Whereas, prevalence rate of CKD stages 3–5 is 1.0% in central Italy, and 5.9% in northeast Germany.
- Pharmaceutical companies
- Research and Development (R&D) companies
- Independent research laboratories
- Market research and consulting service providers
- Medical research laboratories
- Academic medical institutes and universities
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/915 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312